Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine

Debra J. Hendrickson, Dean A Blumberg, Jesse P. Joad, Sanjay Jhawar, Ruth J McDonald

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

A retrospective review of medical records for all pediatric parapneumonic empyema (PPE) patients admitted to our hospital from 1996 to 2006 revealed that PPE increased 5-fold in the post-heptavalent pneumococcal conjugate vaccine (PCV7) period (2001-2005) relative to the pre-PCV7 period (1996-2000), from 13 cases to 65. Most of this increase was associated with culture-negative empyema, which accounted for 61% of all post-2000 cases; 19% was culture-positive pneumococcal empyema. Our analysis indicates that non-PCV7 serotypes became more prevalent at our institution after introduction of the vaccine.

Original languageEnglish (US)
Pages (from-to)1030-1032
Number of pages3
JournalPediatric Infectious Disease Journal
Volume27
Issue number11
DOIs
StatePublished - Nov 2008

Fingerprint

Conjugate Vaccines
Pneumococcal Vaccines
Empyema
Pediatrics
Medical Records
Vaccines

Keywords

  • Empyema, invasive disease
  • Pneumococcal vaccine
  • Pneumococcus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases
  • Microbiology (medical)

Cite this

Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. / Hendrickson, Debra J.; Blumberg, Dean A; Joad, Jesse P.; Jhawar, Sanjay; McDonald, Ruth J.

In: Pediatric Infectious Disease Journal, Vol. 27, No. 11, 11.2008, p. 1030-1032.

Research output: Contribution to journalArticle

@article{3f6e3652e4b44c17a9dc41e59fa36462,
title = "Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine",
abstract = "A retrospective review of medical records for all pediatric parapneumonic empyema (PPE) patients admitted to our hospital from 1996 to 2006 revealed that PPE increased 5-fold in the post-heptavalent pneumococcal conjugate vaccine (PCV7) period (2001-2005) relative to the pre-PCV7 period (1996-2000), from 13 cases to 65. Most of this increase was associated with culture-negative empyema, which accounted for 61{\%} of all post-2000 cases; 19{\%} was culture-positive pneumococcal empyema. Our analysis indicates that non-PCV7 serotypes became more prevalent at our institution after introduction of the vaccine.",
keywords = "Empyema, invasive disease, Pneumococcal vaccine, Pneumococcus",
author = "Hendrickson, {Debra J.} and Blumberg, {Dean A} and Joad, {Jesse P.} and Sanjay Jhawar and McDonald, {Ruth J}",
year = "2008",
month = "11",
doi = "10.1097/INF.0b013e31817e5188",
language = "English (US)",
volume = "27",
pages = "1030--1032",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine

AU - Hendrickson, Debra J.

AU - Blumberg, Dean A

AU - Joad, Jesse P.

AU - Jhawar, Sanjay

AU - McDonald, Ruth J

PY - 2008/11

Y1 - 2008/11

N2 - A retrospective review of medical records for all pediatric parapneumonic empyema (PPE) patients admitted to our hospital from 1996 to 2006 revealed that PPE increased 5-fold in the post-heptavalent pneumococcal conjugate vaccine (PCV7) period (2001-2005) relative to the pre-PCV7 period (1996-2000), from 13 cases to 65. Most of this increase was associated with culture-negative empyema, which accounted for 61% of all post-2000 cases; 19% was culture-positive pneumococcal empyema. Our analysis indicates that non-PCV7 serotypes became more prevalent at our institution after introduction of the vaccine.

AB - A retrospective review of medical records for all pediatric parapneumonic empyema (PPE) patients admitted to our hospital from 1996 to 2006 revealed that PPE increased 5-fold in the post-heptavalent pneumococcal conjugate vaccine (PCV7) period (2001-2005) relative to the pre-PCV7 period (1996-2000), from 13 cases to 65. Most of this increase was associated with culture-negative empyema, which accounted for 61% of all post-2000 cases; 19% was culture-positive pneumococcal empyema. Our analysis indicates that non-PCV7 serotypes became more prevalent at our institution after introduction of the vaccine.

KW - Empyema, invasive disease

KW - Pneumococcal vaccine

KW - Pneumococcus

UR - http://www.scopus.com/inward/record.url?scp=58149156472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149156472&partnerID=8YFLogxK

U2 - 10.1097/INF.0b013e31817e5188

DO - 10.1097/INF.0b013e31817e5188

M3 - Article

C2 - 18845981

AN - SCOPUS:58149156472

VL - 27

SP - 1030

EP - 1032

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 11

ER -